383
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Analysis of blood microbiome dysbiosis in pulmonary sarcoidosis by decision tree model

Article: 2283133 | Received 21 Aug 2023, Accepted 09 Nov 2023, Published online: 22 Nov 2023

References

  • Grunewald J, Grutters JC, Arkema EV, et al. Sarcoidosis. Nat Rev Dis Primer. 2019;5:1.
  • Clarke EL, Lauder AP, Hofstaedter CE, et al. Microbial lineages in sarcoidosis. A metagenomic analysis tailored for low-microbial content samples. Am J Respir Crit Care Med. 2018;197(2):225–10. doi: 10.1164/rccm.201705-0891OC.
  • Gupta S, Shariff M, Chaturvedi G, et al. Comparative analysis of the alveolar microbiome in COPD, ECOPD, sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures. Sci Rep. 2021;11(1):3963. doi: 10.1038/s41598-021-83524-2.
  • Zimmermann A, Knecht H, Häsler R, et al. Atopobium and fusobacterium as novel candidates for sarcoidosis-associated microbiota. Eur Respir J. 2017;50(6):1600746. doi: 10.1183/13993003.00746-2016.
  • Panaiotov S, Filevski G, Equestre M, et al. Cultural isolation and characteristics of the blood microbiome of healthy individuals. AiM. 2018;08(05):406–421. doi: 10.4236/aim.2018.85027.
  • Panaiotov S, Hodzhev Y, Tsafarova B, et al. Culturable and non-culturable blood microbiota of healthy individuals. Microorganisms. 2021;9(7):1464. doi: 10.3390/microorganisms9071464.
  • Carding S, Verbeke K, Vipond DT, et al. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191. doi: 10.3402/mehd.v26.26191.
  • Gerke AK. Treatment of sarcoidosis: a multidisciplinary approach. Front Immunol. 2020;11:545413. doi: 10.3389/fimmu.2020.545413.
  • Amati F, Stainer A, Mantero M, et al. Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases. Int J Mol Sci. 2022;23(2):977–977. doi: 10.3390/ijms23020977.
  • Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 2019;12(4):843–850. doi: 10.1038/s41385-019-0160-6.
  • He Y, Wu W, Zheng H-M, et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med. 2018;24(10):1532–1535. doi: 10.1038/s41591-018-0164-x.
  • Cheng HS, Tan SP, Wong DMK, et al. The blood microbiome and health: current evidence, controversies, and challenges. Int J Mol Sci. 2023;24(6):5633. doi: 10.3390/ijms24065633.
  • Czech L, Stamatakis A, Dunthorn M, et al. Metagenomic analysis using phylogenetic placement—a review of the first decade. Front Bioinform. 2022;2:871393. doi: 10.3389/fbinf.2022.871393.
  • Hernández Medina R, Kutuzova S, Nielsen KN, et al. Machine learning and deep learning applications in microbiome research. ISME Commun. 2022;2(1):98. doi: 10.1038/s43705-022-00182-9.
  • Hernández-Terán A, Mejia-Nepomuceno F, Herrera MT, et al. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes. Sci Rep. 2021;11(1):21297. doi: 10.1038/s41598-021-00851-0.
  • Tsafarova B. Sarcoidosis. Probl Infect Parasit Dis. 2021;49(1):32–36. doi: 10.58395/pipd.v49i1.55.
  • Topçuoğlu BD, Lesniak NA, Ruffin MT, et al. A framework for effective application of machine learning to microbiome-based classification problems. mBio. 2020;11(3):e00434-20. doi: 10.1128/mBio.00434-20.
  • Hodzhev Y, Tsafarova B, Tolchkov V, et al. Visualization of the individual blood microbiome to study the etiology of sarcoidosis. Comput Struct Biotechnol J. 2023;22:50–57. doi: 10.1016/j.csbj.2023.10.027.
  • Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011;183(5):573–581. doi: 10.1164/rccm.201006-0865CI.
  • Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. BioTechniques. 2004;36(5):808–812. doi: 10.2144/04365ST04.
  • Lu J, Rincon N, Wood DE, et al. Metagenome analysis using the kraken software suite. Nat Protoc. 2022;17(12):2815–2839. doi: 10.1038/s41596-022-00738-y.
  • Wood DE, Lu J, Langmead B. Improved metagenomic analysis with kraken 2. Genome Biol. 2019;20(1):257. doi: 10.1186/s13059-019-1891-0.
  • Afgan E, Nekrutenko A, The Galaxy Community, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update. Nucleic Acids Res. 2022;50:w345–W351.
  • Breitwieser FP, Salzberg SL. Pavian: interactive analysis of metagenomics data for microbiome studies and pathogen identification. Schwartz R, editor. Bioinformatics. 2020;36(4):1303–1304. doi: 10.1093/bioinformatics/btz715.
  • Blaxter M, Mann J, Chapman T, et al. Defining operational taxonomic units using DNA barcode data. Philos Trans R Soc Lond B Biol Sci. 2005;360(1462):1935–1943. doi: 10.1098/rstb.2005.1725.
  • Sneath PHA, Sokal RR. Numerical taxonomy: the prin­ciples and practice of numerical classification. San Francisco: W. H. Freeman; 1973.
  • The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi: 10.1038/nature11234.
  • The Integrative HMP (iHMP) Research Network Consortium. The integrative human microbiome project. Nature. 2019;569(7758):641–648. doi: 10.1038/s41586-019-1238-8.
  • Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52(3–4):591–611. doi: 10.1093/biomet/52.3-4.591.
  • Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47(260):583–621. doi: 10.1080/01621459.1952.10483441.
  • Virtanen P, Gommers R, Oliphant TE, et al. SciPy 1.0: fundamental algorithms for scientific computing in python. Nat Methods. 2020;17(3):261–272. doi: 10.1038/s41592-019-0686-2.
  • Studer M, Ritschard G, Gabadinho A, et al. Discrepancy analysis of state sequences. Sociol Methods Res. 2011;40(3):471–510. doi: 10.1177/0049124111415372.
  • Chen X, Wang M, Zhang H. The use of classification trees for bioinformatics. Wiley Interdiscip Rev Data Min Knowl Discov. 2011;1(1):55–63. doi: 10.1002/widm.14.
  • Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in python. J Machine Learning Res. 2011;12:2825–2830.
  • Sammut C, Webb GI, editors. Encyclopedia of machine learning. New York; London: Springer; 2010.
  • Dickson RP, Schultz MJ, van der Poll T, et al. Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. 2020;201(5):555–563. doi: 10.1164/rccm.201907-1487OC.
  • Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78(1):481–504. doi: 10.1146/annurev-physiol-021115-105238.
  • Païssé S, Valle C, Servant F, et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion (Paris). 2016;56(5):1138–1147. doi: 10.1111/trf.13477.
  • Sze MA, Dimitriu PA, Hayashi S, et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1073–1080. doi: 10.1164/rccm.201111-2075OC.
  • Crisafulli E, Bernardinello N, Alfieri V, et al. A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries. Respirol Case Rep. 2019;7(9):e00493. doi: 10.1002/rcr2.493.
  • Dickson RP, Erb-Downward JR, Freeman CM, et al. Changes in the lung microbiome following lung transplantation include the emergence of two distinct pseudomonas species with distinct clinical associations. Davis IC, editor. PLoS One. 2014;9(5):e97214. doi: 10.1371/journal.pone.0097214.
  • Ke L, Chen L, Yaling Y, et al. Investigation on the pathological mechanism of frequent exacerbators with chronic obstructive pulmonary disease based on the characteristics of respiratory flora. Front Med (Lausanne). 2021;8:816802. doi: 10.3389/fmed.2021.816802.
  • Sun Y, Wen M, Liu Y, et al. The human microbiome: a promising target for lung cancer treatment. Front Immunol. 2023;14:1091165. doi: 10.3389/fimmu.2023.1091165.
  • LiPuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23(2):299–323. doi: 10.1128/CMR.00068-09.
  • Coenye T, Goris J, Spilker T, et al. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol. 2002;40(6):2062–2069. doi: 10.1128/JCM.40.6.2062-2069.2002.
  • LiPuma JJ, Currie BJ, Peacock SJ, et al. Burkholderia, stenotrophomonas, ralstonia, cupriavidus, pandoraea, brevundimonas, comamonas, delftia, and acidovorax. In: Jorgensen JH, Carroll KC, Funke G, et al. editors. Manual of clinical microbiology [internet]. Washington, DC, USA: ASM Press; 2015. p. 791–812. doi: http://doi.wiley.com/10.1128/9781555817381.ch43.
  • Aryal S, Nathan SD. Contemporary optimized practice in the management of pulmonary sarcoidosis. Ther Adv Respir Dis. 2019;13:1753466619868935. doi: 10.1177/1753466619868935.